Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Maternal phenylketonuria: an international study.

R Koch1, W Hanley, H Levy

  • 1Children's Hospital of Los Angeles, University of Southern California Los Angeles, California 90027, USA. rkoch8@earthlink.net

Molecular Genetics and Metabolism
|September 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a delayed-release nutrient for appetite control in adults with obesity and type 2 diabetes and initial clinical testing in a single dose randomized controlled trial.

Nutrition & diabetes·2019
Same author

Plasma C-type natriuretic peptide forms and thyroid status in prepubertal children with acquired thyroid disease.

Clinical endocrinology·2011
Same author

Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review.

Journal of inherited metabolic disease·2005
Same author

Maternal Phenylketonuria Collaborative Study (MPKUCS)--the 'outliers'.

Journal of inherited metabolic disease·2004
Same author

Phenylketonuria in adulthood: a collaborative study.

Journal of inherited metabolic disease·2002
Same author

Congenital heart disease in maternal phenylketonuria: report from the Maternal PKU Collaborative Study.

Pediatric research·2001

Maternal phenylketonuria (PKU) management is crucial for preventing congenital anomalies. Adherence to a phenylalanine-restricted diet, especially in women with lower IQs, significantly improves fetal development outcomes.

Area of Science:

  • Medical Genetics
  • Maternal-Fetal Medicine
  • Public Health

Background:

  • Maternal phenylketonuria (PKU) can cause severe congenital anomalies in offspring.
  • Preconceptional dietary management of maternal phenylalanine levels is key to healthy fetal development.

Purpose of the Study:

  • To evaluate factors affecting offspring outcomes in maternal PKU.
  • To identify challenges in maintaining dietary adherence during reproductive years.

Main Methods:

  • A 15-year observational study.
  • Analysis of offspring congenital anomalies in relation to maternal phenylalanine control and socioeconomic factors.

Main Results:

  • Microcephaly occurred in 27% and congenital heart disease in 7% of offspring.

Related Experiment Videos

  • Suboptimal phenylalanine control was linked to lower maternal IQ, socioeconomic status, and unplanned pregnancies.
  • Women off dietary treatment had poorer phenylalanine control.

    • Conclusions:

    • Enhanced support is needed for women with PKU to maintain dietary adherence during reproductive years.
    • Continued adherence to a phenylalanine-restricted diet is vital for normal maternal intelligence and improved fetal development.